What impact does ritlecitinib’s dual inhibition of JAK and TEC pathways have on the immune response in alopecia areata?

Featuring Glynis Ablon, MD | Associate Clinical Professor University of California, Los Angeles Ablon Skin Institute & Research Center Los Angeles, CA | Published December 02, 2024